📊 POCI Key Takeaways
Is Precision Optics Corporation, Inc.. (POCI) a Good Investment?
Precision Optics exhibits structural unprofitability with negative operating income (-$3.4M) and negative free cash flow (-$1.1M) despite $22.8M in revenue, indicating an unsustainable business model. Flat revenue growth (-0.1% YoY), deteriorating EPS (-73.5% YoY), and low gross margins (14.1%) demonstrate a company losing competitive ground in the medical device sector with no evident operational improvement.
Precision Optics Corporation, Inc.. Key Strengths (POCI)
- Strong liquidity position with 2.10x current ratio and 1.74x quick ratio
- Conservative capital structure with 0.07x debt-to-equity ratio and minimal long-term debt of $1.5M
- Adequate cash reserves of $10.7M providing operational runway
POCI Stock Risks: Precision Optics Corporation, Inc.. Investment Risks
- Negative operating and net income combined with negative free cash flow (-$1.1M) indicates unsustainable cash burn despite positive revenue
- Flat revenue growth (-0.1% YoY) and deteriorating EPS (-73.5% YoY) suggest loss of market competitiveness in electromedical devices sector
- Low gross margin of 14.1% and negative operating margins (-14.9%) constrain any path to profitability
Key Metrics to Watch
- Operating cash flow trend - must improve from -$901K burn rate
- Revenue growth acceleration and gross margin expansion required for profitability
- Cash burn rate and months of remaining runway before liquidity stress
Precision Optics Corporation, Inc.. (POCI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.10x current ratio provides a solid financial cushion.
POCI Profit Margin, ROE & Profitability Analysis
POCI vs Healthcare Sector: How Precision Optics Corporation, Inc.. Compares
How Precision Optics Corporation, Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Precision Optics Corporation, Inc.. Stock Overvalued? POCI Valuation Analysis 2026
Based on fundamental analysis, Precision Optics Corporation, Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Precision Optics Corporation, Inc.. Balance Sheet: POCI Debt, Cash & Liquidity
POCI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Precision Optics Corporation, Inc..'s revenue has grown significantly by 79% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.49 indicates the company is currently unprofitable.
POCI Revenue Growth, EPS Growth & YoY Performance
POCI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $4.2M | -$108.3K | $-0.01 |
| Q2 2026 | $4.5M | -$969.7K | $-0.15 |
| Q1 2026 | $4.2M | -$1.3M | $-0.21 |
| Q3 2025 | $4.2M | -$317.1K | $-0.05 |
| Q2 2025 | $4.5M | -$464.4K | $-0.13 |
| Q1 2025 | $4.2M | -$464.4K | $-0.08 |
| Q3 2024 | $5.0M | -$48.5K | $-0.01 |
| Q2 2024 | $4.8M | -$158.7K | $0.06 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Precision Optics Corporation, Inc.. Dividends, Buybacks & Capital Allocation
POCI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Precision Optics Corporation, Inc.. (CIK: 0000867840)
📋 Recent SEC Filings
❓ Frequently Asked Questions about POCI
What is the AI rating for POCI?
Precision Optics Corporation, Inc.. (POCI) has an AI grade of D with 87% confidence, based on fundamental analysis of SEC EDGAR filings.
What are POCI's key strengths?
Claude: Strong liquidity position with 2.10x current ratio and 1.74x quick ratio. Conservative capital structure with 0.07x debt-to-equity ratio and minimal long-term debt of $1.5M.
What are the risks of investing in POCI?
Claude: Negative operating and net income combined with negative free cash flow (-$1.1M) indicates unsustainable cash burn despite positive revenue. Flat revenue growth (-0.1% YoY) and deteriorating EPS (-73.5% YoY) suggest loss of market competitiveness in electromedical devices sector.
What is POCI's revenue and growth?
Precision Optics Corporation, Inc.. reported revenue of $22.8M.
Does POCI pay dividends?
Precision Optics Corporation, Inc.. does not currently pay dividends.
Where can I find POCI SEC filings?
Official SEC filings for Precision Optics Corporation, Inc.. (CIK: 0000867840) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is POCI's EPS?
Precision Optics Corporation, Inc.. has a diluted EPS of $-0.46.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is POCI's fundamental grade?
Based on our AI fundamental analysis in May 2026, Precision Optics Corporation, Inc.. has a D grade with 87% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is POCI stock overvalued or undervalued?
Valuation metrics for POCI: ROE of -17.5% (sector avg: 15%), net margin of -15.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is POCI's AI grade for 2026?
Our dual AI analysis gives Precision Optics Corporation, Inc.. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is POCI's free cash flow?
Precision Optics Corporation, Inc..'s operating cash flow is $-901.1K, with capital expenditures of $227.2K. FCF margin is -5.0%.
How does POCI compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -15.5% (avg: 12%), ROE -17.5% (avg: 15%), current ratio 2.10 (avg: 2).